

Author: Weiser T. Wieland H.A. Doods H.N.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.404, Iss.1, 2000-09, pp. : 133-136
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










Neuropeptide Y receptor antagonists
By Ling A.L.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. :